Bantu lenda sadila bankisi mingi sambu na kubelula kansere ya prostate, yo ke tadila mutindu kansere yango me kuma ngolo mpi mutindu yo me kuma ngolo, mavimpi ya muntu mpi mambu yina yandi ke zolaka.
Bankisi ya nkaka ya bo kesadilaka mingi kele:
1. Kukengila mbote: Mutindu yai ya kusansa ke lombaka nde bo tala mbote-mbote kansere na nsadisa ya ekzame mbala na mbala, kansi bo yantika ve kubelula yo mbala mosi.
Yo lenda vanda mbote sambu na babakala yina kele ti kansere ya prostate yina kebelaka ve ngolo.
2. Kupasudila muntu divumu: Bo kesalaka operasio sambu na kukatula prostate.
Bo lenda sala yo na nzila ya operasio ya kukangula to na laparoscopie (na kusadilaka bima ya fyoti-fyoti mpi bisadilu ya sikisiki).
3. Kusadila radiation: Bo kesadilaka radiation ya ngolo sambu na kufwa baselile ya kansere.
Bo lenda sadila yo na nganda (na nzila ya masini mosi yina kele na nganda ya nitu) to na kati (na nzila ya bima yina bo ketulaka penepene ya tumeur).
4. Kusadila bankisi ya ke basisaka hormone: Kusadila nkisi yai ke sadisaka na kufyotuna hormone ya bakala (androgène) na nitu, mpi yo lenda lembisa to kukanga kuyela ya kansere ya prostate.
Bo lenda sadila yo yo mosi to kumosi ti bankisi yankaka.
5. Kimoterapi: Bo kesadilaka bankisi yai sambu na kufwa baselile ya kansere.
Bo lenda sadila yo sambu na kansere ya prostate yina me yalumuka mpi me kuma na bandambu ya nkaka ya nitu.
6. Kusansa ti bima yina kebebisaka nitu: Kusansa yai kesadisaka nitu na kunwana ti kansere.
Bo lenda sadila yo sambu na kansere ya prostate yina me yela mingi mpi yina ke belukaka ve na bankisi ya nkaka.
7. Kusansa yina bo ketulaka na kisika mosi buna: Kusansa yai ketulaka na kisika mosi buna ba gènes to ba protéine yina kesadisaka baselile ya kansere na kuyela mpi kuzinga.
Bo lenda sadila yo sambu na kansere ya prostate yina me yela mingi mpi yina ke belukaka ve na bankisi ya nkaka.
8. Cryothérapie: Bo kesadilaka madidi mingi sambu na kukanga baselile ya kansere mpi kufwa yo.
Bo lenda sadila yo sambu na kansere ya prostate yina kele na luyantiku to sambu na kansere yina mevutuka na nima ya kusadila bankisi yankaka.
9. Ultra-son ya ngolo (HIFU): Nkisi yai ke sadilaka makelele ya ngolo sambu na kuyoka mpi kufwa baselile ya kansere.
Bo lenda sadila yo sambu na kansere ya prostate yina kele na luyantiku to sambu na kansere yina mevutuka na nima ya kusadila bankisi yankaka.
10. Kukengila na dikebi yonso: Mutindu yai kelombaka kutala mbote kansere na nsadisa ya ekzame ya mbala na mbala, kansi kuyantika ve lusansu kana bidimbu memonana ve to mebaluka ve.
Yo lenda vanda mbote sambu na bambuta yina kenyokwama na kansere ya prostate yina keyelaka malembe-malembe mpi bayina kele ti maladi yankaka ya ngolo.
Yo kele mfunu na kusolula mambu yonso ya nge lenda sala ti munganga sambu na kuzaba mutindu ya mbote ya kusadila konso muntu.
Wang Y, Chen J, Wu Z, Ding W, Gao S, Gao Y, Xu C: Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it. Br J Pharmacol. 2021, 178 (2): 239-261.
Talkar SS, Patravale VB: Gene Therapy for Prostate Cancer: A Review. Endocr Metab Immune Disord Drug Targets. 2021, 21 (3): 385-396.
Šamija I, Fröbe A: CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER. Acta Clin Croat. 2019, 58 (Suppl 2): 76-81.
Akaza H, Hinotsu S, Usami M, Ogawa O, Kagawa S, Kitamura T, Tsukamoto T, Naito S, Hirao Y, Murai M, Yamanaka H, Namiki M: The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE. J Urol. 2006, 176 (6 Pt 2): S47-9.
Abraham-Miranda J, Awasthi S, Yamoah K: Immunologic disparities in prostate cancer between American men of African and European descent. Crit Rev Oncol Hematol. 2021, 164 (): 103426.
de Vrij J, Willemsen RA, Lindholm L, Hoeben RC, Bangma CH, Barber C, Behr JP, Briggs S, Carlisle R, Cheng WS, Dautzenberg IJ, de Ridder C, Dzojic H, Erbacher P, Essand M, Fisher K, Frazier A, Georgopoulos LJ, Jennings I, Kochanek S, Koppers-Lalic D, Kraaij R, Kreppel F, Magnusson M, Maitland N, Neuberg P, Nugent R, Ogris M, Remy JS, Scaife M, Schenk-Braat E, Schooten E, Seymour L, Slade M, Szyjanowicz P, Totterman T, Uil TG, Ulbrich K, van der Weel L, van Weerden W, Wagner E, Zuber G: Adenovirus-derived vectors for prostate cancer gene therapy. Hum Gene Ther. 2010, 21 (7): 795-805.
Lee E, Ha S, Logan SK: Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. PLoS One. 2015, 10 (10): e0141589.
['Disclaimer: mambu ya kimunganga']
['Site Internet yai kele kaka sambu na kulonga mpi kupesa bansangu, kansi yo kele ve sambu na kupesa bandongisila ya minganga to kusadila bantu ya nkaka kisalu.']
['Bo fwete sadila ve bansangu yina bo kepesa sambu na kuzaba to kubelula maladi mosi buna, mpi bantu yina kesosa bandongisila ya kimunganga fwete solula ti munganga yina kele ti nswa ya kusala kisalu yina.']
['Tala nde, ba-apareyi yina ke pesaka bamvutu na bangiufula ke vandaka ve mbote ntangu bo ke sadilaka ntalu, mu mbandu ntalu ya bantu yina bo me zaba nde bo ke belaka maladi mosi buna.']
['Sosa ntangu yonso bandongisila ya munganga to ya muntu ya nkaka ya me zaba kisalu ya kusansa bantu sambu na maladi na nge. Kuvila ve bandongisila ya munganga to kusukinina ve na kusosa yo sambu na mambu ya nge me tanga na site Internet yai. Kana nge ke yindula nde nge kele ti maladi ya ngolo, binga 911 to kwenda nswalu na lupitalu ya me finama. Site Internet yai to mutindu nge ke sadila yo ke sala ve nde nge kuma nduku ya munganga to nkengi ya maladi.']
['Banswa ya kusonika']
['Nsiku ya Banswa ya Bansoniki ya Internet ya mvu 1998, 17 U.S.C. § 512 (DMCA) ke pesa nswa na bantu yina kele ti banswa ya bansoniki ya ke kwikila nde mambu yina ke monana na Internet ke fwa banswa na bo na nsi ya nsiku ya banswa ya bansoniki ya États-Unis. ']
['Kana nge ke mona nde mambu ya nge ke tanga na site Internet na beto to na baservice na beto ke fwa banswa na nge, nge (to muntu yina ke twadisaka nge) lenda tindila beto mukanda sambu na kulomba nde beto katula yo to kukanga nzila na nge ya kusadila yo.']
['Bo fwete tinda bansangu na mukanda na nzila ya email (tala na "Kutuba na beto" sambu na kuzaba adresi ya email).']
['Nsiku ya DMCA ke lomba nde na mukanda na nge ya ke tubila nde bo me fwa nsiku ya banswa ya bantu, nge sonika mambu yai: (1) mutindu ya kutendula kisalu yina bo me fwa nsiku; (2) mutindu ya kutendula mambu yina bo me fwa nsiku mpi bansangu yina ta sadisa beto na kuzaba kisika yina mambu yango kele; (3) bansangu ya nge lenda sadila sambu na kusolula ti nge, tanga mpi adresi na nge, nimero ya telefone mpi adresse ya e-mail; (4) mambu ya nge me tuba nde nge ke kwikila nde mambu yina nge ke tuba kele ve na nswa ya munkwa-kisalu to muntu yina me pesa nswa na yo to na nsiku ya leta.']
['5) na nima ya kupesa nzikisa na mukanda yina nge me sonika, nge fwete ndima nde mambu yina nge me tuba kele ya kieleka mpi nde nge kele ti nswa ya kusadila banswa yina bo me bebisa.']
['mpi (6) kidimbu ya muntu yina kele ti nswa ya kubasisa yo to ya muntu yina kele ti nswa ya kusala mambu na zina na yandi. ']
['Kana nge pesa ve bansangu yai yonso, yo lenda sala nde bo sala ve mambu nswalu.']
['Kusolula']
['Beno tindila beto email kana beno kele na ngyufula to ngindu.']
How to treat prostate cancer?
There are several treatment options available for prostate cancer, depending on the stage and aggressiveness of the cancer, as well as the patient's overall health and personal preferences.
Some common treatments include:
1. Active surveillance: This approach involves closely monitoring the cancer with regular checkups and tests, rather than immediately starting treatment.
It may be suitable for men with low-risk prostate cancer.
2. Surgery: A prostatectomy is a surgical procedure to remove the prostate gland.
It can be done through open surgery or laparoscopically (using small incisions and specialized tools).
3. Radiation therapy: This treatment uses high-energy radiation to kill cancer cells.
It can be delivered externally (from a machine outside the body) or internally (through implants placed near the tumor).
4. Hormone therapy: This treatment reduces the levels of male hormones (androgens) in the body, which can slow or stop the growth of prostate cancer.
It can be used alone or in combination with other treatments.
5. Chemotherapy: This treatment uses drugs to kill cancer cells.
It may be used for advanced prostate cancer that has spread to other parts of the body.
6. Immunotherapy: This treatment helps the immune system fight cancer.
It may be used for advanced prostate cancer that has not responded to other treatments.
7. Targeted therapy: This treatment targets specific genes or proteins that help cancer cells grow and survive.
It may be used for advanced prostate cancer that has not responded to other treatments.
8. Cryotherapy: This treatment uses extreme cold to freeze and kill cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
9. High-intensity focused ultrasound (HIFU): This treatment uses high-frequency sound waves to heat and destroy cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
10. Watchful waiting: This approach involves closely monitoring the cancer with regular checkups and tests, but not starting treatment unless symptoms appear or change.
It may be suitable for older men with slow-growing prostate cancer and other serious health conditions.
It is important to discuss all treatment options with a healthcare team to determine the best course of action for each individual case.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Na kiteso ya']
['BioMedLib kesadilaka ba ordinatere ya bo mesalaka bo mosi (ba algorithme ya kulonguka na masini) sambu na kubasisa bangyufula ti bamvutu.']
['Beto me yantika ti mikanda ya kimunganga ya bamilio 35 ya PubMed/Medline mpi basite ya Internet ya RefinedWeb.']
